Latest Breaking News On - Distribution logistics division - Page 1 : comparemela.com

Genexine and KGbio received the first market approval for novel long-acting Erythropoietin, Efepoetin alfa, from The Indonesian Food and Drug Authority (BPOM)

SEOUL, South Korea (BUSINESS WIRE) Oct 23, 2023

Soult ukpyolsiSouth koreaKalbe farmaKalbe genexine biologics kgbioRoche mirceraJongsoo leeSungjune hongKalbe genexine biologicsGenexine incConsumer health divisionPrescription pharmaceuticals divisionIndonesian ministry of foodIndonesia stock exchangeNutritional divisionDistribution logistics divisionGenexine biologics

Henlius Expands Collaboration with KGbio to Develop, Commercialize and Supply Henlius novel anti-PD-1 mAb HANSIZHUANG in MENA

/PRNewswire/ Shanghai Henlius Biotech, Inc. (2696.HK) has entered into an exclusive license agreement with PT Kalbe Genexine Biologics ("KGbio"), an.

United statesSaudi arabiaUnited kingdomUnited arab emiratesKalbe farmaJason zhuKalbe genexine biologics kgbioNutritionals divisionPrescription pharmaceuticals divisionNational medicinal products administrationPrnewswire shanghai henlius biotech incConsumer health divisionDistribution logistics divisionEuropean unionIndonesia stock exchangeBusiness development of henlius

Henlius Expands Collaboration With Kgbio To Develop, Commercialize And Supply Henlius Novel Anti-Pd-1 Mab Hansizhuang In Mena

Henlius Expands Collaboration With Kgbio To Develop, Commercialize And Supply Henlius Novel Anti-Pd-1 Mab Hansizhuang In Mena
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

Saudi arabiaUnited kingdomUnited statesUnited arab emiratesKalbe farmaHenland kgbioKalbe genexine biologics kgbioJason zhuConsumer health divisionPrnewswire shanghai henlbiotech incEuropean unionNutritionals divisionNational medicinal products administrationPrescription pharmaceuticals divisionBusiness development of henliusJournal of the american medical association

PT Kalbe Farma Tbk : Kalbe Announced Dividend of 52% from Net Profit

Jakarta, May 3rd, 2023 - PT Kalbe Farma Tbk will distribute cash dividend of Rp 1.76 trillion or 38 per share. The distribution of cash dividend has been approved by the Shareholders. | May 4, 2023

Jakarta rayaRhenald kasaliRonny hadianaKartika setiabudySantoso oenBernadette ruth irawati setiadyBernadus karmin winataLilis halimJos iwan atmadjajaNutritionals divisionDistribution logistics divisionShareholders of the companyIndonesia stock exchangeCompany nominationGedung kalbe business innovation centerPublic accountant firm

PT Kalbe Farma Tbk : Kalbe Maintained Double Digit Top Line Growth in the First Quarter of 2023

Jakarta, April 28, 2023 - PT Kalbe Farma Tbk and Subsidiaries today announced that net sales reached Rp 7,869 billion in the first quarter of 2023, growing by 12.2% compared to the. | April 28, 2023

Jakarta rayaKalbe genexine biologics kgbioAventis pharmaIndonesia stock exchangeGlobal starway synergy co ltdNutritionals divisionConsumer health divisionNational health insuranceDistribution logistics divisionPrescription pharmaceuticals divisionPrescription drugs divisionFarma tbkLogistics divisionGenexine biologicsPt kalbe farma tbk stock exchangePress release